One of the most common questions we hear is: “Do I qualify?” The answer depends on your health profile, not a simple number on a scale. Here’s how GLP3 physicians evaluate candidacy and what you need to know before your first consultation.
Clinical Eligibility Criteria
FDA guidelines and clinical evidence establish clear criteria for GLP-1 and related weight loss medications. Your GLP3 physician uses these as a starting framework, then evaluates your complete medical picture.
BMI-Based Criteria
The primary eligibility thresholds are:
- BMI 30 or higher: You may qualify for GLP-1 medication based on BMI alone. A BMI of 30 is the clinical threshold for obesity.
- BMI 27-29.9 with a weight-related condition: If your BMI falls in the overweight range AND you have a comorbidity like type 2 diabetes, hypertension, high cholesterol (dyslipidemia), obstructive sleep apnea, or cardiovascular disease, you may qualify.
Not sure what your BMI is? It’s calculated as weight in kilograms divided by height in meters squared. For reference, a 5’8″ person weighing 200 pounds has a BMI of approximately 30.4.
Beyond BMI: The Full Picture
BMI is a useful screening tool, but it doesn’t tell the whole story. Your GLP3 physician also considers:
- Weight loss history: Have you tried diet and exercise, commercial programs, or other interventions without lasting success? A history of attempted weight loss strengthens the case for medical intervention.
- Current medications: Some medications cause weight gain as a side effect (certain antidepressants, beta-blockers, insulin, corticosteroids). Your physician evaluates how your current medications interact with potential weight loss treatment.
- Metabolic health markers: Blood sugar levels, A1C, cholesterol panel, and blood pressure readings help your doctor understand your metabolic baseline and choose the right medication class.
- Mental health considerations: Weight loss medication works best when combined with healthy coping strategies. Your physician screens for eating disorders and other conditions that require specialized support.
- Contraindications: Certain conditions may prevent you from using GLP-1 medications, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe gastrointestinal conditions.
Who Typically Qualifies
Based on clinical evidence and our patient population, these profiles commonly qualify for GLP-1 or dual/triple agonist therapy through GLP3:
Adults with Obesity (BMI 30+)
If your BMI is 30 or above and you’re an otherwise healthy adult, you’re likely a strong candidate. Your physician will confirm there are no contraindications and select the appropriate medication and starting dose.
Overweight Adults with Type 2 Diabetes
GLP-1 medications were originally developed for diabetes management. If you have type 2 diabetes and a BMI of 27+, these medications offer dual benefits — weight loss and improved blood sugar control. Many patients reduce or eliminate diabetes medications as they lose weight.
Adults with Hypertension or Cardiovascular Risk
Clinical trials show GLP-1 medications reduce cardiovascular risk factors beyond just weight loss. If you carry excess weight and have high blood pressure, elevated cholesterol, or other heart disease risk factors, medical weight loss may be both appropriate and protective.
People Who’ve Plateaued with Diet and Exercise
If you’ve genuinely committed to lifestyle changes and hit a wall, that’s not a personal failure. For many people, hormonal and metabolic factors create a biological ceiling that willpower alone can’t break through. GLP-1 medications address the biological barriers that keep your body from releasing stored fat.
Adults Managing Sleep Apnea or Joint Pain from Excess Weight
Obstructive sleep apnea and weight-bearing joint pain improve dramatically with weight loss. If excess weight is causing or worsening these conditions, your physician may recommend GLP-1 therapy as part of a comprehensive treatment approach.
Who May Not Qualify (or Needs Additional Evaluation)
GLP-1 medications aren’t appropriate for everyone. Your physician will discuss alternatives if:
- You’re pregnant, planning pregnancy, or breastfeeding: GLP-1 medications are not approved for use during pregnancy. You must stop treatment at least 2 months before planning to conceive.
- You have a history of medullary thyroid carcinoma: Animal studies showed thyroid tumor risk. While human evidence is limited, this is a firm contraindication.
- You have pancreatitis: GLP-1 medications may increase pancreatitis risk. Active or recent pancreatitis typically disqualifies candidates.
- You have severe gastrointestinal disease: Conditions like gastroparesis or inflammatory bowel disease may be worsened by GLP-1 medications, which slow gastric emptying.
- Your BMI is under 27: Current FDA approval and clinical guidelines set BMI 27 (with comorbidities) as the minimum threshold. Vanity weight loss is outside the clinical scope of these medications.
What About People with Diabetes Already on Insulin?
Yes, many people on insulin qualify for GLP-1 therapy — but medication management becomes more nuanced. When GLP-1 medications improve blood sugar control, insulin doses often need to be reduced to prevent hypoglycemia (dangerously low blood sugar). Your GLP3 physician coordinates these adjustments carefully, monitoring your blood sugar response at each check-in.
This is one of the reasons physician oversight matters. Adjusting multiple diabetes and weight loss medications simultaneously requires clinical judgment, not algorithms.
How the GLP3 Evaluation Process Works
Candidacy assessment at GLP3 follows a structured process:
- Online Health Assessment: Complete a detailed questionnaire covering your medical history, current medications, weight history, allergies, and health goals. This takes approximately 10-15 minutes.
- Physician Review: A board-certified physician reviews your complete health profile. If additional information is needed (recent lab work, medical records from another provider), your care team reaches out.
- Telehealth Consultation: You meet your physician via secure video. They discuss your health picture, explain medication options, and answer your questions. There’s no commitment at this stage — this consultation helps you make an informed decision.
- Treatment Decision: If you and your physician agree that GLP-1 or related medication is appropriate, they prescribe your starting medication and dose, establish your check-in schedule, and get you enrolled in your program tier.
The entire process from initial assessment to starting treatment typically takes 3-7 days, depending on whether additional health information is needed.
What If I’m Not Sure?
That’s exactly what the initial consultation is for. You don’t need to commit to anything before speaking with a physician. Many patients come to their consultation unsure whether they qualify or whether medication is the right choice. Your physician’s job is to give you clear information so you can decide.
There’s no charge for the initial evaluation. If you don’t qualify, or if you decide GLP-1 therapy isn’t right for you, there’s no obligation.
Schedule Your Free Evaluation | View Program Options
Disclaimer: Eligibility for GLP-1 or related medications is determined by a board-certified physician based on individual medical evaluation. Meeting BMI criteria does not guarantee prescription. This content is educational and does not constitute medical advice.